Lipopolysaccharides of Brucella abortus and Brucella melitensis induce nitric oxide synthesis in rat peritoneal macrophages

Infection and Immunity

Volumn 68, Issue 3, 2000, Pages 1740-1745

  López Urrutia, Luis ^a,b   Alonso, Andrés ^c   Nieto, Maria Luisa ^b   Bayón, Yolanda ^c   Orduña, Antonio ^a,b   Crespo, Mariano Sanchez ^c  

^a UNIVERSITY OF VALLADOLID   (Spain)

^b HOSPITAL CLÍNICO UNIVERSITARIO DE VALLADOLID   (Spain)

^c Universidad de Valladolid y Consejo Superior de Investigaciones Científicas   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; LIPID A; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

ANIMAL CELL; ARTICLE; BACTERIAL GROWTH; BRUCELLA ABORTUS; BRUCELLA MELITENSIS; BRUCELLOSIS; CELL INCLUSION; CONTROLLED STUDY; ENZYME RELEASE; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SEPTIC SHOCK;

ANIMALS; BRUCELLA ABORTUS; BRUCELLA MELITENSIS; INTERFERON TYPE II; LIPID A; LIPOPOLYSACCHARIDES; MACROPHAGES, PERITONEAL; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; RATS; RATS, WISTAR; RNA, MESSENGER;

EID: 0343920708     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.68.3.1740-1745.2000     Document Type: Article

References (45)

1. Amura, C. R., R. Silverstein, and D. C. Morrison. 1998. Mechanisms involved in the pathogenesis of sepsis are not necessarily reflected by in vitro cell activation studies. Infect. Immun. 66:5372-5378.
2. Aragón, V., R. Díaz, E. Moreno, and I. Moriyón. 1996. Characterization of Brucella abortus and Brucella melitensis native haptens as outer membrane O-type polysaccharides independent from the smooth lipopolysaccharide. J. Bacteriol. 178:1070-1079.
3. Baldwin, C. L., and A. J. Winter. 1994. Macrophages and Brucella. Immunol. Ser. 60:363-380.
4. Bayón, Y., A. Alonso, and M. Sánchez Crespo. 1997. Stimulation of Fcγ receptors in rat peritoneal macrophages induces the expression of nitric oxide synthase and chemokines by mechanisms showing different sensitivities to antioxidants and nitric oxide donors. J. Immunol. 159:887-894.
5. Berman, D. T., and R. S. Kurtz. 1987. Relationship of biological activities to structures of Brucella abortus endotoxin and LPS. Ann. Inst. Pasteur Microbiol. 138:98-101.
6. Canning, P. C. 1990. Phagocyte function in resistance to brucellosis, p. 151-163. In L. G. Adams (ed.), Advances in brucellosis research. Texas A&M University Press, College Station.
7. Canning, P. C., J. A. Roth, and B. L. Deyoe. 1986. Release of 5′-guanosine monophosphate and adenine by Brucella abortus and their role in the intracellular survival of the bacteria. J. Infect. Dis. 154:464-470.
8. Chomczynski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:156-159.
9. Church, G. M., and W. Gilbert. 1984. Genomic sequencing. Proc. Natl. Acad. Sci. USA 81:1991-1995.
10. AL, p. 377-388. In N. R. Krieg and J. G. Holt (ed.), Bergey's manual of systematic bacteriology, vol. 1. Williams & Wilkins, Baltimore, Md.
11. Díaz, R., L. M. Jones, D. Leong, and J. B. Wilson. 1968. Surface antigens of smooth brucellae. J. Bacteriol. 96:893-901.
12. Dugas, B., P. Debre, and S. Moncada. 1995. Nitric oxide, a vital poison inside the immune and inflammatory network. Res. Immunol. 146:664-670.
13. English, B. K., C. C. Patrick, S. L. Orlicek, R. McCordic, and J. L. Shenep. 1996. Lipoteichoic acid from viridans streptococci induces the production of tumor necrosis factor and nitric oxide by murine macrophages. J. Infect. Dis. 174:1348-1351.
14. Fang, F. C. 1997. Perspectives series: host/pathogen interactions. Mechanisms of nitric oxide-related antimicrobial activity. J. Clin. Investig. 99:2818-2825.
15. Freer, E., E. Moreno, I. Moriyón. J. Pizarro-Cerdá, A. Weintraub, and J. P. Gorvel. 1996. Brucella-Salmonella lipopolysaccharide chimeras are less permeable to hydrophobic probes and more sensitive to cationic peptides and EDTA than are their native Brucella sp. counterparts. J. Bacteriol. 178:5867-5876.
16. 15N]nitrate in biological fluids. Anal. Biochem. 126:131-138.
17. Gross, A., S. Spiesser, A. Terraza, B. Rouot, E. Caron, and J. Dornand. 1998. Expression and bactericidal activity of nitric oxide synthase in Brucella suis-infected murine macrophages. Infect. Immun. 66:1309-1316.
18. Jiang, X., B. Leonard, R. Benson, and C. L. Baldwin. 1993. Macrophage control of Brucella abortus: role of reactive oxygen intermediates and nitric oxide. Cell. Immunol. 151:309-319.
19. Kress, S., P. Klooker, V. Kaufmann, N. Sloot, J. F. Riemann, and H. Brass. 1997. Brucellosis with fatal endotoxic shock. Med. Klin. 92:561-566.
20. Leong, D., R. Díaz, K. Milner, J. Rudbach, and J. B. Wilson. 1970. Some structural and biological properties of Brucella endotoxin. Infect. Immun. 1:174-182.
21. Lowenstein, C. J., E. W. Alley, P. Raval, A. M. Snowman, S. H. Snyder, S. W. Russell, and W. J. Murphy. 1993. Macrophage nitric oxide synthase gene: two upstream regions mediate induction by interferon-γ and lipopolysaccharide. Proc. Natl. Acad. Sci. USA 90:9730-9734.
22. MacMicking, J., Q. W. Xie, and C. Nathan. 1997. Nitric oxide and macrophage function. Annu. Rev. Immunol. 15:323-350.
23. Moncada, S., and A. Higgs. 1993. The L-arginine-nitric oxide pathway. N. Engl. J. Med. 329:2002-2012.
24. Moncada, S., R. M. Palmer, and E. A. Higgs. 1991. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol. Rev. 43:109-142.
25. Moreno, E., D. T. Berman, and L. A. Boettcher. 1981. Biological activities of Brucella abortus lipopolysaccharides. Infect. Immun. 31:362-370.
26. Moreno, E., M. W. Pitt, L. M. Jones, G. G. Schurig, and D. T. Berman. 1979. Purification and characterization of smooth and rough lipopolysaccharides from Brucella abortus. J. Bacteriol. 138:361-369.
27. Mozaffarian, N., J. W. Berman, and A. Casadevall. 1995. Immune complexes increase nitric oxide production by interferon-γ stimulated murine macrophage-like J774.16 cells. J. Leukoc. Biol. 57:657-662.
28. Nathan, C. 1997. Inducible nitric oxide synthase: what difference does it make? J. Clin. Investig. 100:2417-2423.
29. Nathan, C., and Q. W. Xie. 1994. Nitric oxide synthases: roles, tolls, and controls. Cell 78:915-918.
30. Orduña, A., C. Orduña, J. M. Eiros, M. A. Bratos, P. Gutiérrez, P. Alonso, and T. A. Rodríguez. 1991. Inhibition of the degranulation and myeloperoxidase activity of human polymorphonuclear neutrophils by Brucella melitensis. Microbiologia 7:113-119.
31. Parrillo, J. E. 1993. Pathogenetic mechanisms of septic shock. N. Engl. J. Med. 328:1471-1477.
32. Rasool, O., E. Freer, E. Moreno, and C. Jarstrand. 1992. Effect of Brucella abortus lipopolysaccharide on oxidative metabolism and lysozyme release by human neutrophils. Infect. Immun. 60:1699-1702.
33. Riley, L. K., and D. C. Robertson. 1984. Ingestion and intracellular survival of Brucella abortus in human and bovine polymorphonuclear leukocytes. Infect. Immun. 46:224-230.
34. Robertson, D. C., L. K. Riley, and D. L. Kreutzer. 1979. Intracellular survival of smooth and rough strains of Brucella, p. 150-153. In D. Schlessinger (ed.), Microbiology. American Society for Microbiology, Washington, D.C.
35. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed., p. 7.1-7.78. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
36. Sangari, F. J., and J. Agüero. 1996. Molecular basis of Brucella pathogenicity: an update. Microbiologia 12:207-218.
37. Schmidt, H. H., and U. Walter. 1994. NO at work. Cell 78:919-925.
38. Smith, L. D., and T. A. Ficht. 1990. Pathogenesis of Brucella. Crit. Rev. Microbiol. 17:209-230.
39. Stuehr, D. J., and M. A. Marletta. 1987. Induction of nitrite/nitrate synthesis in murine macrophages by BCG infection, lymphokines, or interferon-γ. J. Immunol. 139:518-525.
40. Vedder, H., W. Schreiber, A. Yassouridis, S. Gudewill, C. Galanos, and T. Pollmacher. 1999. Dose-dependence of bacterial lipopolysaccharide (LPS) effects on peak response and time course of the immune-endocrine host response in humans. Inflamm. Res. 48:67-74.
41. Vouldoukis, I., D. Mazier, P. Debre, and M. D. Mossalayi. 1995. Nitric oxide and human infectious diseases. Res. Immunol. 146:689-692.
42. Weinberg, J. B., M. A. Misukonis, P. J. Shami, S. N. Mason, D. L. Sauls, W. A. Dittman, E. R. Wood, G. K. Smith, B. McDonald, and K. E. Bachus. 1995. Human mononuclear phagocyte inducible nitric oxide synthase (iNOS): analysis of iNOS mRNA, iNOS protein, biopterin, and nitric oxide production by blood monocytes and peritoneal macrophages. Blood 86: 1184-1195.
43. Xie, Q. W., Y. Kashiwabara, and C. Nathan. 1994. Role of transcription factor NF-κB/Rel in induction of nitric oxide synthase. J. Biol. Chem. 269: 4705-4708.
44. Zhan, Y., and C. Cheers. 1995. Endogenous interleukin-12 is involved in resistance to Brucella abortus infection. Infect. Immun. 63:1387-1390.
45. Zhan, Y., Z. Liu, and C. Cheers. 1996. Tumor necrosis factor-α and interleukin-12 contribute to resistance to the intracellular bacterium Brucella abortus by different mechanisms. Infect. Immun. 64:2782-2786.